Key Financial Inc’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-812
Closed -$24.1K 1330
2023
Q4
$24.1K Hold
812
0.01% 556
2023
Q3
$12.9K Hold
812
﹤0.01% 657
2023
Q2
$15.3K Hold
812
0.01% 637
2023
Q1
$3.12K Hold
812
﹤0.01% 887
2022
Q4
$3.88K Hold
812
﹤0.01% 834
2022
Q3
$4K Hold
812
﹤0.01% 860
2022
Q2
$4K Hold
812
﹤0.01% 862
2022
Q1
$4K Hold
812
﹤0.01% 849
2021
Q4
$6K Buy
812
+12
+2% +$75 ﹤0.01% 699
2021
Q3
$5K Hold
800
﹤0.01% 721
2021
Q2
$4K Hold
800
﹤0.01% 726
2021
Q1
$6K Hold
800
﹤0.01% 583
2020
Q4
$5K Buy
+800
New +$4.67K ﹤0.01% 570
2020
Q2
Sell
-800
Closed -$3K 685
2020
Q1
$3K Buy
+800
New +$3.5K ﹤0.01% 584

Other funds holding IMGN

Key Financial Inc's IMGN Position: Q1 2024 in Review

Key Financial Inc sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 812 shares — an estimated $24.1K sold.

Key Financial Inc first reported a position in IMGN in Q1 2020 and held it in 14 quarters. The position peaked at $24.1K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Key Financial Inc reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Key Financial Inc sold 812 Immunogen Inc shares in Q1 2024, an estimated $24.1K.
  • Key Financial Inc first reported a position in Immunogen Inc in Q1 2020 and held it in 14 quarters.
  • Key Financial Inc's Immunogen Inc position peaked at $24.1K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Key Financial Inc's 13F filing for Q1 2024, filed 1 May 2024.